Table 1

Table 1. Breast Cancer Drugs in the Market

Product	Class	Target	Clinical Stage	Manufacturer
ABT-510	Antiangiogenic	Pro-angiogenic growth factors	Phase I	Abbott
Arimidex			Market	AstraZeneca
Aromasin			Market	Pfizer
Dendritic/ cancer cell fusion	Vaccine	Immune system	Phase II	Genezyme
Femara	Hormone	Aromatase inhibitor	Market	Novartis
ISIS2503	Antisense	Ha-ras	Phase II	Isis
MDX-010	Antibody	CTLA-4	Phase II	Medarex
Panzem	Antiangiogenic	Microtubule	Phase II	EntreMed
Perifosine	Kinase inhibitor	AKT/protein kinase B	Phase II	Aeterna Zentaris
Genasense	Small molecule	Bcl-2	Phase II	Aventis and Genta
Taxotere	Tubulin inhibitor	Microtubulin	Market	Aventis
Taxol			Market	Bristol-Myers Squibb
Theratope	Vaccine	Sialyl Tn	Phase III	Biomira
Tykerb				GlaxoSmithKline